Lonza Group Ltd (LZAGY)
62.99
+1.32
(+2.14%)
USD |
OTCM |
Nov 01, 16:00
Lonza Group Shareholders Equity (Quarterly): 10.40B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.40B |
| June 30, 2024 | 10.40B |
| December 31, 2023 | 11.25B |
| June 30, 2023 | 11.46B |
| June 30, 2023 | 11.46B |
| December 31, 2022 | 11.43B |
| June 30, 2022 | 10.49B |
| June 30, 2022 | 10.49B |
| December 31, 2021 | 10.67B |
| June 30, 2021 | 7.890B |
| June 30, 2021 | 7.890B |
| December 31, 2020 | 7.800B |
| June 30, 2020 | 6.805B |
| June 30, 2020 | 6.805B |
| December 31, 2019 | 6.702B |
| June 30, 2019 | 6.320B |
| June 30, 2019 | 6.320B |
| December 31, 2018 | 6.316B |
| June 30, 2018 | 6.372B |
| June 30, 2018 | 6.372B |
| December 31, 2017 | 6.296B |
| June 30, 2017 | 5.558B |
| June 30, 2017 | 5.558B |
| Date | Value |
|---|---|
| December 31, 2016 | 2.262B |
| June 30, 2016 | 2.094B |
| June 30, 2016 | 2.094B |
| December 31, 2015 | 2.160B |
| June 30, 2015 | 2.115B |
| June 30, 2015 | 2.115B |
| December 31, 2014 | 2.154B |
| June 30, 2014 | 2.332B |
| June 30, 2014 | 2.332B |
| December 31, 2013 | 2.396B |
| June 30, 2013 | 2.270B |
| June 30, 2013 | 2.270B |
| December 31, 2012 | 2.304B |
| June 30, 2012 | 2.437B |
| June 30, 2012 | 2.437B |
| December 31, 2011 | 2.273B |
| June 30, 2011 | 2.575B |
| December 31, 2010 | 2.554B |
| June 30, 2010 | 2.205B |
| December 31, 2009 | 2.245B |
| June 30, 2009 | 2.166B |
| December 31, 2008 | 1.745B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.702B
Minimum
Dec 2019
11.46B
Maximum
Jun 2023
9.463B
Average
10.40B
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 137.30M |
| CRISPR Therapeutics AG | 1.981B |
| Addex Therapeutics Ltd | 14.07M |
| NLS Pharmaceutics Ltd | -9.268M |
| Molecular Partners AG | 173.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.89B |
| Total Liabilities (Quarterly) | 9.422B |
| Debt to Equity Ratio | 0.4058 |
| Current Ratio | 2.042 |
| Net Debt Paydown Yield | -1.54% |